Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 175

1.

Cutaneous melanoma: a model to study cancer metastasis.

Leong SP, Gershenwald JE, Soong SJ, Schadendorf D, Tarhini AA, Agarwala S, Hauschild A, Soon CW, Daud A, Kashani-Sabet M.

J Surg Oncol. 2011 May 1;103(6):538-49. doi: 10.1002/jso.21816. Review.

PMID:
21480247
[PubMed - indexed for MEDLINE]
2.

Progression of cutaneous melanoma: implications for treatment.

Leong SP, Mihm MC Jr, Murphy GF, Hoon DS, Kashani-Sabet M, Agarwala SS, Zager JS, Hauschild A, Sondak VK, Guild V, Kirkwood JM.

Clin Exp Metastasis. 2012 Oct;29(7):775-96. doi: 10.1007/s10585-012-9521-1. Epub 2012 Aug 15. Review. Erratum in: Clin Exp Metastasis. 2012 Oct;29(7):797-9.

PMID:
22892755
[PubMed - indexed for MEDLINE]
3.

Prediction of sentinel lymph node micrometastasis by histological features in primary cutaneous malignant melanoma.

Mraz-Gernhard S, Sagebiel RW, Kashani-Sabet M, Miller JR 3rd, Leong SP.

Arch Dermatol. 1998 Aug;134(8):983-7.

PMID:
9722728
[PubMed - indexed for MEDLINE]
4.

Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.

Wagner JD, Ranieri J, Evdokimow DZ, Logan T, Chuang TY, Johnson CS, Jung SH, Wenck S, Coleman JJ 3rd.

Plast Reconstr Surg. 2003 Aug;112(2):486-97.

PMID:
12900606
[PubMed - indexed for MEDLINE]
5.

Examination of regional lymph nodes by sentinel node biopsy and molecular analysis provides new staging facilities in primary cutaneous melanoma.

Blaheta HJ, Ellwanger U, Schittek B, Sotlar K, MacZey E, Breuninger H, Thelen MH, Bueltmann B, Rassner G, Garbe C.

J Invest Dermatol. 2000 Apr;114(4):637-42.

PMID:
10733666
[PubMed - indexed for MEDLINE]
Free Article
6.

Clinical relevance of sentinel lymph node status examined with conventional histology and molecular biology.

Micciolo R, Boi S, Paoli L, Cristofolini P, Girlando S, Dalla Palma P, Cristofolini M.

Tumori. 2009 May-Jun;95(3):298-302.

PMID:
19688967
[PubMed - indexed for MEDLINE]
7.

Single-institution experience in the management of patients with clinical stage I and II cutaneous melanoma: results of sentinel lymph node biopsy in 240 cases.

Rex J, Paradelo C, Mangas C, Hilari JM, Fernández-Figueras MT, Fraile M, Alastrué A, Ferrándiz C.

Dermatol Surg. 2005 Nov;31(11 Pt 1):1385-93.

PMID:
16416605
[PubMed - indexed for MEDLINE]
8.

Sentinel lymph node biopsy in melanoma patients with clinically negative regional lymph nodes--one institution's experience.

Nowecki ZI, Rutkowski P, Nasierowska-Guttmejer A, Ruka W.

Melanoma Res. 2003 Feb;13(1):35-43.

PMID:
12569283
[PubMed - indexed for MEDLINE]
9.

Pathologic staging of melanoma.

Ruiter DJ, Spatz A, van den Oord JJ, Cook MG; Pathology Committee of the European Organization Research and Treatment of Cancer (EORTC) Melanoma Group.

Semin Oncol. 2002 Aug;29(4):370-81. Review.

PMID:
12170440
[PubMed - indexed for MEDLINE]
10.

Melanoma patient staging: histopathological versus molecular evaluation of the sentinel node.

Davids V, Kidson SH, Hanekom GS.

Melanoma Res. 2003 Jun;13(3):313-24. Review.

PMID:
12777989
[PubMed - indexed for MEDLINE]
11.

The role of sentinel lymph node biopsy for melanoma.

Shen J, Wallace AM, Bouvet M.

Semin Oncol. 2002 Aug;29(4):341-52. Review.

PMID:
12170437
[PubMed - indexed for MEDLINE]
12.

Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.

Niakosari F, Kahn HJ, McCready D, Ghazarian D, Rotstein LE, Marks A, Kiss A, From L.

Arch Dermatol. 2008 Apr;144(4):462-7. doi: 10.1001/archderm.144.4.462.

PMID:
18427039
[PubMed - indexed for MEDLINE]
13.

Lymphatic mapping and sentinel lymph node biopsy in the management of primary cutaneous melanoma: report of a single-centre experience.

Cecchi R, De Gaudio C, Buralli L, Innocenti S.

Tumori. 2006 Mar-Apr;92(2):113-7.

PMID:
16724689
[PubMed - indexed for MEDLINE]
14.

Role for lymphatic mapping and sentinel lymph node biopsy in patients with thick (> or = 4 mm) primary melanoma.

Gershenwald JE, Mansfield PF, Lee JE, Ross MI.

Ann Surg Oncol. 2000 Mar;7(2):160-5.

PMID:
10761797
[PubMed - indexed for MEDLINE]
15.

Detection of micrometastasis in sentinel lymph nodes of patients with primary cutaneous melanoma.

Blaheta HJ, Schittek B, Breuninger H, Garbe C.

Recent Results Cancer Res. 2001;158:137-46. Review.

PMID:
11092041
[PubMed - indexed for MEDLINE]
16.

Sentinel lymph node biopsy in cutaneous melanoma: a case-control study.

Koskivuo I, Talve L, Vihinen P, Mäki M, Vahlberg T, Suominen E.

Ann Surg Oncol. 2007 Dec;14(12):3566-74. Epub 2007 Oct 9.

PMID:
17924169
[PubMed - indexed for MEDLINE]
17.

Update on the use of sentinel node biopsy in patients with melanoma: who and how.

Chao C, McMasters KM.

Curr Opin Oncol. 2002 Mar;14(2):217-20. Review.

PMID:
11880714
[PubMed - indexed for MEDLINE]
18.

Impact of false-negative sentinel lymph node biopsy on survival in patients with cutaneous melanoma.

Caracò C, Marone U, Celentano E, Botti G, Mozzillo N.

Ann Surg Oncol. 2007 Sep;14(9):2662-7. Epub 2007 Jun 28.

PMID:
17597345
[PubMed - indexed for MEDLINE]
19.

The staging of malignant melanoma and the Florida Melanoma Trial.

Reintgen DS, Jakub JW, Pendas S, Swor G, Giuliano R, Shivers S.

Ann Surg Oncol. 2004 Mar;11(3 Suppl):186S-91S.

PMID:
15023749
[PubMed - indexed for MEDLINE]
20.

[Impact of sentinel lymph node biopsy on the treatment of melanoma].

Santinami M, Baldi M, Tragni G, Maurichi A, Moglia D, Bono A, Bartoli C, Patuzzo R, Pennacchioli E, Cascinelli N.

Tumori. 2003 Jul-Aug;89(4 Suppl):273-5. Italian.

PMID:
12903619
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk